Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women | Zendy

Marianne Caico | Zendy; Emmanuel Oger | Zendy; Geneviève PluBureau | Zendy; Jacqueline Conard | Zendy; Guy Meyer | Zendy; H. Lévesque | Zendy; Nathalie Trillot | Zendy; M.T. Barrellier | Zendy; Denis Wahl | Zendy; Joseph Emmerich | Zendy; PierreYves Scarabin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women

Author(s) -

Marianne Caico,

Emmanuel Oger,

Geneviève PluBureau,

Jacqueline Conard,

Guy Meyer,

H. Lévesque,

Nathalie Trillot,

M.T. Barrellier,

Denis Wahl,

Joseph Emmerich,

PierreYves Scarabin

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.642280

Subject(s) - medicine , estrogen , odds ratio , hormone therapy , confounding , progestogen , case control study , transdermal , menopause , gynecology , breast cancer , cancer , pharmacology

Oral estrogen therapy increases the risk of venous thromboembolism (VTE) in postmenopausal women. Transdermal estrogen may be safer. However, currently available data have limited the ability to investigate the wide variety of types of progestogen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research